MARCH 9, 2007
  Penn Study Suggests Test for Tumor Suppressor p53 Is Needed to Prescreen Patients for Blood Cancer Drugs
Back to Article
Image    1

Green staining depicts tumor cells dying after treatment with proteasome inhibitors. In the left panel, the tumor lacks p53, and only a fraction of the cells are killed. In the right panel, the tumor produces p53, resulting in massive cell death.

Image Credit: Andrei Thomas-Tikhonenko, PhD, University of Pennsylvania School of Medicine; Blood.

Download high-resolution version (512 KB, JPEG, 300 DPI)

Tumor Cells With and Without p53

About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2016, The Trustees of the University of Pennsylvania